<DOC>
	<DOCNO>NCT01271023</DOCNO>
	<brief_summary>The purpose study test insulin management system ( `` Control-to-Range ( CTR ) system '' ) inpatient set see system safe effective enough test future at-home study . The system include ( 1 ) DexCom Seven Plus Continuous Glucose Monitoring ( CGM ) device measure blood sugar , ( 2 ) laptop computer determine much insulin need , ( 3 ) Insulet OmniPod insulin pump delivers insulin . The study include two hospital stay consist meal exercise scenario . Both hospital stay 24+ hour day night . The study include 50 individual 7 clinical center United States , France , Israel , Italy .</brief_summary>
	<brief_title>Inpatient Evaluation Automated Closed-Loop Control-to-Range System</brief_title>
	<detailed_description>Clinical Research Center ( CRC ) Session Detail ( closed-loop control active element ) Day 1 ( 24+ hour ) : 1 . Admission 7:00 AM 2 . Standardized breakfast normal bolus 9:00 AM 3 . Lunch normal bolus 1:00 PM 4 . Dinner normal bolus 7:00 PM 5 . Overnight sleep 6 . Breakfast miss meal bolus follow user alert correction bolus 7 . Discharge Day 2 ( 24+ hour ) : 1 . Admission 7:00 AM 2 . Standardized breakfast normal bolus 9:00 AM 3 . Lunch normal bolus 1:00 PM 4 . Exercise 5 . Dinner normal bolus 7:00 PM 6 . Overnight sleep 7 . Breakfast overbolus 7:00 AM 8 . Discharge Meal bolus semi-automated , manual meal announcement physician/nurse , automate bolus recommendation system , automate delivery bolus follow confirmation recommendation . Between-meal insulin dose fully automate ; bolus confirmation physician/nurse request closed-loop controller determines carbohydrate may necessary avoid hypoglycemia follow bolus .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Clinical diagnosis type 1 diabetes least one year use insulin pump least 6 month The diagnosis type 1 diabetes base investigator 's judgment ; C peptide level antibody determination need . Age 12 65 year Hemoglobin A1c ( HbA1c ) 5.0 % 10.5 % , measure DCA2000 equivalent device For female , currently know pregnant Demonstration proper mental status cognition study An understanding willingness follow protocol sign inform consent assent Diabetic ketoacidosis past 6 month Severe hypoglycemia result seizure loss consciousness 12 month prior enrollment History seizure disorder ( except hypoglycemic seizure ) . Subjects history seizure may include study receive write clearance neurologist treatment seizure disorder Coronary artery disease heart failure . Subjects history coronary artery disease may include study receive write clearance cardiologist Cystic fibrosis Active infection A known medical condition judgment investigator might interfere completion protocol follow example : Inpatient psychiatric treatment past 6 month either subject subject 's primary care giver ( i.e. , parent guardian ) Presence know adrenal disorder Abnormal liver renal function ( Transaminase &gt; 2 time upper limit normal , Creatinine &gt; 1.5 mg/dL ) Active gastroparesis If antihypertensive , thyroid , antidepressant lipid lower medication , lack stability medication past 2 month prior enrollment study Uncontrolled thyroid disease Abuse alcohol Note : Adequately treat thyroid disease celiac disease exclude subject enrollment A recent injury body limb , muscular disorder , use medication , carcinogenic disease , significant medical disorder injury , medication disease judgment investigator affect completion exercise protocol Current use beta blocker medication Hematocrit &lt; 30 % ( labs drawn screen visit within one month prior screen purpose suffice enrollment purpose related hematocrit ) Use pseudoephedrine 48 hour prior Clinical Research Center ( CRC ) admission</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>